Advanced search
Publication Cover
OncoTargets and Therapy Volume 14, 2021 - Issue
Submit an article Journal homepage
78
Views
1
CrossRef citations to date
0
Altmetric
Case Report

Case Report of a Breast Mass with Three Types of Malignant Tumors—Squamous Cell Carcinoma, Invasive Ductal Carcinoma, and Breast Sarcoma

Chao Li1 Department of Breast Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315000, People’s Republic of China;2 Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315000, People’s Republic of ChinaView further author information
,
Hongfei Fang3 Ningbo Diagnostic Pathology Center, Ningbo, Zhejiang, 315000, People’s Republic of ChinaView further author information
&
Hongfeng Lu1 Department of Breast Surgery, Hwa Mei Hospital, University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315000, People’s Republic of China;2 Ningbo Institute of Life and Health Industry, University of Chinese Academy of Sciences, Ningbo, Zhejiang, 315000, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 3193-3197 | Published online: 14 May 2021

References

  • Coughlin SS. Epidemiology of breast cancer in women. Adv Exp Med Biol. 2019;1152:9–29. PMID: 31456177. doi:10.1007/978-3-030-20301-6_2.
  • Institute NC. Cancer stat facts: female breast cancer; 2019. Available from: https://seer.cancer.gov/statfacts/html/breast.html. Accessed November 20, 2020.
  • Harbeck N, Gnant M. Breast cancer. Lancet. 2017;389(10074):1134–1150. PMID: 27865536. doi:10.1016/S0140-6736(16)31891-8.
  • Vergel JC, Osorio AM, Garcia Mora M, et al. Breast sarcomas: experience of a reference center in Colombia. Cureus. 2019;11(7):e5078. PMID: 31516788; PMCID: PMC6721959. doi:10.7759/cureus.5078.
  • Dianatinasab M, Fararouei M, Daneshi N, et al. Heterogeneity in risk factors for ductal and lobular breast carcinomas: a case-control study. Int J Cancer. 2019;145(11):2917–2925. PMID: 30719718. doi:10.1002/ijc.32182.
  • Makki J. Diversity of breast carcinoma: histological subtypes and clinical relevance. Clin Med Insights Pathol. 2015;8:CPath.S31563. doi:10.4137/CPath.S31563.
  • Lim SZ, Ong KW, Tan BK, Selvarajan S, Tan PH. Sarcoma of the breast: an update on a rare entity. J Clin Pathol. 2016;69(5):373–381. PMID: 26729013. doi:10.1136/jclinpath-2015-203545.
  • Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How many etiological subtypes of breast cancer: two, three, four, or more? J Natl Cancer Inst. 2014;106(8):dju165. PMID: 25118203; PMCID: PMC4148600. doi:10.1093/jnci/dju165.
  • Lahat G, Lev D, Gerstenhaber F, Madewell J, Le-petross H, Pollock RE. Sarcomas of the breast. Expert Rev Anticancer Ther. 2012;12(8):1045–1051. PMID: 23030224. doi:10.1586/era.12.82.
  • González-Martínez S, Pérez-Mies B, Carretero-Barrio I, et al. Molecular features of metaplastic breast carcinoma: an infrequent subtype of triple negative breast carcinoma. Cancers (Basel). 2020;12(7):1832. PMID: 32650408; PMCID: PMC7408634. doi:10.3390/cancers12071832.
  • Puri A, Reddy TP, Patel TA, Chang JC. Metastatic triple-negative breast cancer: established and emerging treatments. Breast J. 2020;26(9):1793–1796. PMID: 32578306. doi:10.1111/tbj.13946.
  • Li C, Li X, Li G, et al. Identification of a prognosis-associated signature associated with energy metabolism in triple-negative breast cancer. Oncol Rep. 2020;44(3):819–837. PMID: 32582991; PMCID: PMC7388543. doi:10.3892/or.2020.7657.
  • Scow JS, Reynolds CA, Degnim AC, Petersen IA, Jakub JW, Boughey JC. Primary and secondary angiosarcoma of the breast: the Mayo Clinic experience. J Surg Oncol. 2010;101(5):401–407. PMID: 20119983. doi:10.1002/jso.21497.
  • Johnstone PA, Pierce LJ, Merino MJ, Yang JC, Epstein AH, DeLaney TF. Primary soft tissue sarcomas of the breast: local-regional control with post-operative radiotherapy. Int J Radiat Oncol Biol Phys. 1993;27(3):671–675. PMID: 8226163. doi:10.1016/0360-3016(93)90395-c.
  • Barrow BJ, Janjan NA, Gutman H, et al. Role of radiotherapy in sarcoma of the breast–a retrospective review of the M.D. Anderson experience. Radiother Oncol. 1999;52(2):173–178. PMID: 10577703. doi:10.1016/s0167-8140(99)00070-5.
  • Tierney JF, Stewart LA, Parmar M, Fletcher C, Yang JC. Adjuvant chemotherapy for localised resectable soft-tissue sarcoma of adults: meta-analysis of individual data. Sarcoma Meta-analysis Collaboration. Lancet. 1997;350(9092):1647–1654. PMID: 9400508. doi:10.1016/S0140-6736(97)08165-8
  • Pervaiz N, Colterjohn N, Farrokhyar F, Tozer R, Figueredo A, Ghert M. A systematic meta-analysis of randomized controlled trials of adjuvant chemotherapy for localized resectable soft-tissue sarcoma. Cancer. 2008;113(3):573–581. PMID: 18521899. doi:10.1002/cncr.23592.
  • Le Cesnc A, van Glabbeke M, Woll PJ, et al. The end of adjuvant chemotherapy era with doxorubicin based regimen in resected high-grade soft tissue sarcoma: pooled analysis of the two STBSG-EORTC Phase III clinical trials. J Clin Oncol. 2008;26:559s.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.